Armed robbery in Revesby8h
First-Ever Drug Cuts Heart Attacks, Strokes in Diabetes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Daily8h
Use of Generic DPP4i + SGLT2i FDCs by Indian Physicians - The DiSi Survey
The Indian phenotype of T2DM patients is associated with clustering of cardiovascular risk factors, increased insulin ...
Daily11h
Dapagliflozin prevents renal injury by improving mitochondrial function and reducing oxidative stress in diabetes patients: Study
China: A recent study published in the Journal of Diabetes and its Complications highlighted dapagliflozin's (DAPA) ...
Breakthrough medication significantly cuts risk of heart attacks and strokes: Lancet study
A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...
Rolling Out20h
Diabetes drugs show promise in reducing COPD complications
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
Science Daily21h
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...